The ROI of real-world data: Understanding the current and future state of RWD

Published on October 22, 2025

From clinical trials to regulatory submissions to HEOR research, the value of real-world data (RWD) is clear. So how are today’s pharma leaders using RWD in commercialization strategies, and where are the gaps in realizing its full potential? This infographic reveals the results of Norstella’s survey of 200 life sciences executives about their use of […]

Continue reading on website
Other news

LinQ Cohort: Accelerate feasibility, targeting, and planning

October 21, 2025
Finding the right patients and HCPs should be fast, but today’s cohorting process slows progress across the lifecycle. This infographic explores how LinQ Cohort, powered by NorstellaLinQ’s linked, tokenized real-world data, helps you: Instantly find and size precise patient populations. Search across structured and unstructured data — EMR, labs, claims, and notes. Explore feasibility, design […]

Real-world data in 2025 and beyond: Closing the strategy gap

October 22, 2025
Real-world data has already proven its power to transform patient outcomes, accelerate clinical development, and strengthen commercial strategies, but its full value is realized only when pharma organizations approach it with a cohesive, forward-looking strategy. Our white paper, Real-world data in 2025 and beyond: Closing the strategy gap, surveyed 200 life sciences executives to gather […]